Methylations of Tryptophan-Modified Naphthoquinone Affect Its Inhibitory Potential toward Aβ Aggregation
Authors:
- Ehud GazitEGEhud Gazit
- Daniel SegalDSDaniel Segal
- 31 January 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 117 (6) , 1780-1789
Abstract
Aggregation of amyloid beta (Aβ) is the hallmark of Alzheimer’s disease (AD). Small molecules inhibiting Aβ can be valuable therapeutics for AD. We have previously reported that 1,4-naphthoquinon-2-yl-l-tryptophan (NQTrp), reduces aggregation and oligomerization of Aβ in vitro and in vivo. In silico analysis further showed that certain functional groups of NQTrp, not in the aromatic rings, are also involved in binding and inhibiting Aβ. To better understand the exact mode of action and identify the groups crucial for NQTrp inhibitory activity, we conducted structure–activity analysis. Four derivatives of NQTrp were studied in silico: a D-isomer, two single-methylated and one double-methylated derivative. In silico results showed that the NQTrp groups involved in hydrogen bonds are the anilinic NH (i.e., the NH linker between the quinone and tryptophan moieties), the quinonic carbonyls, and the carboxylic acid. These predictions were supported by in vitro results. Our results should aid in designing improved small-molecule inhibitors of Aβ aggregation for treating AD.Keywords
This publication has 41 references indexed in Scilit:
- The Genetics of Alzheimer Disease: Back to the FutureNeuron, 2010
- Aβ aggregation and possible implications in Alzheimer's disease pathogenesisJournal of Cellular and Molecular Medicine, 2009
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007
- Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's diseaseJournal of Neurochemistry, 2005
- The role of prefibrillar assemblies in the pathogenesis of amyloid diseasesDrugs of the Future, 2004
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assembliesJournal of Neuroscience Research, 2002
- Amyloid pores from pathogenic mutationsNature, 2002
- Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid PolypeptideJournal of Biological Chemistry, 2001
- Chapter 29 Neuropathological changes in Alzheimer disease1994